Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
2022; Elsevier BV; Volume: 399; Issue: 10343 Linguagem: Inglês
10.1016/s0140-6736(22)00941-2
ISSN1474-547X
AutoresMichela Antonelli, Joan Capdevila Pujol, Tim D. Spector, Sébastien Ourselin, Claire J. Steves,
Tópico(s)COVID-19 and Mental Health
ResumoThe omicron variant of SARS-CoV-2 (PANGO B.1.1.529) spread rapidly across the world, out-competing former variants soon after it was first detected in November, 2021. According to the Our World in Data COVID-19 database, In Europe, the number of confirmed cases reported between December, 2021, and March, 2022 (omicron period) has exceeded all previously reported cases. Omicron appears to cause less severe acute illness than previous variants, at least in vaccinated populations. However, the potential for large numbers of people to experience long-term symptoms is a major concern, and health and workforce planners need information urgently to appropriately scale resource allocation.
Referência(s)